Life Sciences

Whether your team of researchers and innovators is developing a new drug or medical device, seeking FDA approval, devising an exit strategy, going public or staying private, Weaver’s diverse team of professionals possesses deep knowledge of the intellectual property landscape, regulatory requirements, reimbursement strategies and commercial aspects. With a profound depth and breadth of experience in the life sciences industry, our professionals can guide you carefully and confidently through any phase of your development process.

Connect with us

Featured

Trending
Insights & Resources

Article

Health Care’s Most Recent Cyber Incident Reveals Industry-Wide Vulnerabilities

Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.

Article

What’s Hiding Under the Hood: The Need for Tax Due Diligence

In a business sale, due diligence is critical to mitigate the risk of unexpected tax issues for buyers and sellers. Find out key components of tax due diligence.

Article

Does Deductibility of R&E Expenditures Have a Chance?

A summary of changes to R&E expenditure tax treatment in the proposed Tax Relief for American Families and Workers Act of 2024.

Article

Building in the Safeguards

Administrative, physical, and technical safeguards are an essential element of HIPAA security and essential for protecting PHI and ePHI.

Article

The Who and How of HIPAA: Understanding Terms, Scope and Applicability

HIPAA’s requirements apply to more than doctors and hospitals. Protect your business and clients by learning about key requirements including who needs to comply.

Article

Who Needs a HIPAA Security Assessment? You May Be Surprised: Rules Touch Many Non-Medical Businesses

Non-medical businesses may be surprised that they are subject to HIPAA because they have clients handling ePHI.

Explore all insights

Assisting you to go public.

Weaver offers integrated services that help you with compliance standards for developing new drugs and devices, going public and establishing IPOs, selling your company and investor relations. Our team knows how to plan your exit strategy and how to structure your taxes — no matter what you decide.

Once you’re public, our professionals can help you with comprehensive tax, audit advisory services for public companies. Our experience gives us the ability to ask the right questions and to help you with some of the most important transitions you’ll face.

Helping you to stay private.

Our professionals know the tax structures and exit strategies for staying private, too. Weaver’s team offers valuations, equity instruments, audit preparation and a host of services covering regulatory standards and business process improvements for the life sciences industry. We’ll help you stabilize and be prepared for new opportunities as they come.

Meet the team